Ellie Fund’s Post

One in 8 women will get a breast cancer diagnosis. Breast cancer is the second most common cause of cancer death in U.S. women. Yet fewer than 50% of eligible women participate in annual screening. A study published this week found that annual mammography screening from age 40 to 79 reduces breast cancer mortality by nearly 42%. Early detection saves lives. ➡️ https://lnkd.in/gXk8-xpA #mammograms #yearlymammograms #breastcancer #breastcancerscreenings #breastcancerawareness #earlydetection #earlydetectionsaveslives

Canadians often turn to search engines to gather information about their breast cancer diagnosis. However, relying solely on these sources can expose patients and their families to inaccurate and misleading information. Progress CONNECT offers a reliable source of information and provide meaningful context compared to overwhelming online resources. With over 50 different types of breast cancer, understanding personalized management options is crucial. Progress CONNECT offers customized information to empower patients with relevant knowledge. Each person is different — and each breast cancer diagnosis is too. Progress CONNECT will provide streamlined, personalized information to patients. We invite Canadian breast cancer patients to know more at: progressCONNECT.ca #ProgressCONNECT #breastcancerresearch #breastcancerknowledge #breastcancerdiagnosis #ResearchMatters 

Though breast cancer incidence has increased yearly since the mid-2000s, the ACS claims that, as of 2020, the mortality rate among females had declined 43% since its peak in 1989. The reasons for the decline were the factors Breast Cancer Awareness Month was started for: earlier detection via mammography, increased awareness of breast cancer testing, and improvements in treatment due in part to increased research and funding. https://lnkd.in/eUjZR4Ct #BreastCancer

Many barriers to tackle the breast cancer prevalence remain. Small incremental steps and larger overarching policies to make meaning full gains. Access to screening, diagnosis, timely care, time and access to therapeutic modalities (surgical/medical), risk reduction strategies crossing the barriers of race/ethnicity and SES...

🤔 Are you, as a breast cancer patient, concerned about clinical trials? Discover below what healthcare professionals say about clinical trials! In the last month of our Care For Your Breasts campaign, we want to address this important but often less-discussed topic – clinical trials. While the treatment of breast cancer has taken significant strides in recent decades, the need for better, personalised, and simultaneously safe new developments remains substantial. Read all about clinical trials in breast cancer here:  NL: https://lnkd.in/ez8nkByU FR: https://lnkd.in/eHcj6ecE

🌟 Exciting News in Breast Cancer Research! 🌟 A groundbreaking vaccine, born from decades of research, has been tested on a small group of women with triple-negative breast cancer (TNBC). The initial trial of 16 women showed promising results, with participants reporting no adverse effects and, importantly, no cancer recurrence. 🎉 The next phases of clinical trials are in the works. Let's celebrate the strides in breast cancer research 💖 Read more here: https://lnkd.in/entwwR2A. #BreastCancerResearch #MedicalInnovation #HopeInHealthcare

Check out this article in in which Jennier Douglas opens up about her breast cancer battle and her experiences with guidewire localization—highlighting the highs, lows, and everything in between. Dive into her story to understand more about the realities of breast cancer treatment and the future advancements in patient care. Read her full story here: https://lnkd.in/eP6HBX9D Interested in the latest innovations for breast cancer patients? Message us today to learn more. #BreastCancerAwareness #PatientStories #MedicalAdvancements

Today I joined 2 webinars designed to address educational needs specific to advanced practice providers who care for patients with breast cancer. We navigated expert insights and recent clinical updates regarding 2 main subjects: 1) building the necessary skills to optimize care of patients with high-risk HR-positive HER2-negative breast cancer; 2) improvement of the knowledge, competence, and performance in the optimal use of HER2-targeted agents for patients with breast cancer.

Discovering the right breast cancer clinical trial is a critical aspect of managing your #healthcare journey. https://lnkd.in/gEHUctuP This guide simplifies learning about clinical trials available and finding clinical trials that may be right for you. Learn Look Locate, we understand that finding the right clinical trial can be overwhelming. That’s why, in partnership with Quantum Leap Healthcare Collaborative, BreastCancerTrials.org, we have made it our mission to simplify the process and provide you with direct access to the most current and comprehensive list of breast cancer clinical trials available. I hope this page is found by those who need it most, it is so important for #people to have easy access to clinical trials, the breast cancer journey is complex enough so it is our goal to simplify everything all in one place in a way that resonates. #doctors #physicians #healthnews #cancer #womenshealth

March 3rd is Triple Negative Breast Cancer (TNBC) Awareness Day. In #TNBC, the cancer cells do not have three common factors that often guide treatment decisions. TNBC accounts for about 10% of all female breast cancer cases in the United States. Learn the facts about TBNC - https://lnkd.in/gKRAt-EV If you are an individual living with this diagnosis, we are here for you. #breastcancer #triplenegativebreastcancer